PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

358.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 425.50
  • 52 Week Low: 237.50
  • Currency: UK Pounds
  • Shares Issued: 286.55m
  • Volume: 98,387
  • Market Cap: £1,025.86m

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Key Personnel

Senior Independent Director: Dame Marjorie Scardino
CEO: Daphne Zohar
Chairman: Christopher Viehbacher
Executive Director: Bharatt Chowrira
Independent Non-Executive Director: Kiran Mazumdar Shaw
Independent Non-Executive Director: Raju Kucherlapati
Independent Non-Executive Director: John LaMattina
Non-Executive Dir: Robert Langer

Contact Details

Address: 8th Floor, 20 Farringdon Street, London, United Kingdom, EC4A 4AB
Website: http://www.puretechhealth.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
Overseas Listings: BATSLON:PRTCL
ISIN: GB00BY2Z0H74

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 358.00p
Change Today -2.00p
% Change -0.56 %
52 Week High 425.50
52 Week Low 237.50
Volume 98,387
Shares Issued 286.55m
Market Cap £1,025.86m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.43% below the market average15.43% below the market average15.43% below the market average15.43% below the market average15.43% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Price Trend
6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average
6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average
Income Not Available
Growth
88.57% below the market average88.57% below the market average88.57% below the market average88.57% below the market average88.57% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
16:35 23,475 @ 358.00p
16:29 34 @ 359.50p
16:29 312 @ 359.50p
16:29 76 @ 359.50p
16:29 324 @ 359.50p

PRTC Key Personnel

CEO Daphne Zohar
Chair Christopher Viehbacher

Top of Page